Reduction of prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats

Pharmacopsychiatry

Volumn 43, Issue 3, 2010, Pages 99-109

  Wolf, R ^a,b   Matzke, K ^b   Paelchen, K ^b   Dobrowolny, H ^b   Bogerts, B ^b   Schwegler, H ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; IBOTENIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL COUNT; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; EXCITOTOXICITY; FEMALE; MALE; MEASUREMENT; NERVE CELL DIFFERENTIATION; NONHUMAN; POSTHUMOUS CARE; POSTNATAL CARE; PREPULSE INHIBITION; PRIORITY JOURNAL; PUBERTY; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SPRAGUE DAWLEY RAT; STARTLE REFLEX; THALAMUS;

AGE FACTORS; AGING; ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; IBOTENIC ACID; MALE; RATS; SCHIZOPHRENIA; SENSORY GATING; STARTLE REACTION; THALAMUS;

EID: 77952073143     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1242823     Document Type: Article

References (68)

1. Al Amin HA, Shannon WC, Weinberger DR. Lipska BK Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry 2001 49 528-539
2. Al Amin HA, Weinberger DR, Lipska BK. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav Pharmacol 2000 11 269-278
3. Andreasen NC. The role of the thalamus in schizophrenia. Can J Psychiatry 1997 42 27-33
4. Andreasen NC, Ehrhardt JC, Swayze VW, etal. Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 1990 47 35-44
5. Ashe PC, Chlan-Fourney J, Juorio AV, etal. Brain-derived neurotrophic factor (BDNF) MRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Brain Res 2002 956 126-135
6. Bakshi VP, Geyer MA. multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 1998 18 8394-8401
7. Bast T, Zhang WN, Heidbreder C, etal. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience 2001 103 325-335
8. Braff DL, Light GA. The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues Clin Neurosci 2005 7 125-135
9. Brickman AM, Buchsbaum M S, Shihabuddin L, etal. Thalamus size and outcome in schizophrenia. Schizophr Res 2004 71 473-484
10. Byne W, Buchsbaum MS, Mattiace LA, etal. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 2002 159 59-65
11. Byne W, Hazlett EA, Buchsbaum MS, etal. The thalamus and schizophrenia: current status of research. Acta Neuropathol 2009 117 347-368
12. Chan WY, Chia MY, Yang GL, etal. Duration of illness, regional brain morphology and neurocognitive correlates in schizophrenia. Ann Acad Med Singapore 2009 38 388
13. Coscia DM, Narr L, Robinson DG, etal. Volumetric and shape analysis of the thalamus in first-episode schizophrenia. Hum Brain Mapp 2009 30 1236-1245
14. Danos P, Baumann B, Bernstein HG, etal. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res 1998 82 1-10
15. Fendt M, Lex A, Falkai P, etal. Behavioural alterations in rats following neonatal hypoxia and effects of clozapine: Implications for schizophrenia. Pharmacopsychiatry 2008 41 138-145
16. Fukumoto-Motoshita M, Matsuura M, Ohkubo T, etal. Hyperfrontality in patients with schizophrenia during saccade and antisaccade tasks: a study with FMRI. Psychiatry Clin Neurosci 2009 63 209-217
17. Geyer MA, Braff L. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 1987 13 643-668
18. Geyer MA, Krebs-Thomson K, Braff DL, etal. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001 156 117-154
19. Goto K, Ueki A, Iso H, etal. Reduced prepulse inhibition in rats with entorhinal cortex lesions. Behav Brain Res 2002 134 201-207
20. Graham FK. Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 1975 12 238-248
21. Hazlett EA, Buchsbaum MS, Haznedar MM, etal. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology 1998 35 186-198
22. Hazlett EA, Buchsbaum MS, Tang CY, etal. Thalamic activation during an attention-to-prepulse startle modification paradigm: a functional MRI study. Biol Psychiatry 2001 50 281-291
23. Heckers S. Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 1997 23 403-421
24. Howard R, Mellers J, Petty R, etal. Magnetic resonance imaging volumetric measurements of the superior temporal gyrus, hippocampus, parahippocampal gyrus, frontal and temporal lobes in late paraphrenia. Psychol Med 1995 25 495-503
25. Jones EG. Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997 23 483-501
26. Kodsi MH, Swerdlow NR. Regulation of prepulse inhibition by ventral pallidal projections. Brain Res Bull 1997 43 219-228
27. Konick LC, Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 2001 49 28-38
28. Kumari V, Antonova E, Geyer MA, etal. A FMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol 2007 10 463-477
29. Kumari V, Antonova E, Zachariah E, etal. Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans. Neuroimage 2005 26 1052-1058
30. Kumari V, Gray JA, Geyer MA, etal. Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 2003 122 99-113
31. Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: A critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) 2002 162 97-101
32. Kumari V, Soni W, Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 1999 156 1046-1051
33. Lacroix L, Spinelli S, White W, etal. The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion. Neuroscience 2000 97 459-468
34. Le Pen G, Grottick AJ, Higgins GA, etal. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia. Behav Pharmacol 2000 11 257-268
35. Le Pen G, Kew J, Alberati D, etal. Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor. Biol Psychiatry 2003 54 1162-1170
36. Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 2002 27 1-11
37. Levin ED, Christopher NC. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 223-229
38. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993 9 67-75
39. Lipska BK, Khaing ZZ, Weickert CS, etal. BDNF MRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci 2001 14 135-144
40. Lipska BK, Luu S, Halim ND, etal. Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat. Behav Brain Res 2003 141 105-111
41. Lipska BK, Weinberger DR. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 1994 10 199-205
42. Lipska BK, Weinberger DR. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA 1995 92 8906-8910
43. Meincke U, Morth D, Voss T, etal. Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis a longitudinal study. Eur Arch Psychiatry Clin Neurosci 2004 254 415-421
44. Oke AF, Adams RN. Elevated thalamic dopamine: Possible link to sensory dysfunctions in schizophrenia. Schizophr Bull 1987 13 589-604
45. Oke AF, Putz C, Adams RN, etal. Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects. Psychiatry Res 1992 45 203-208
46. Oranje B, Van Oel CJ, Gispen-De Wied CC, etal. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol 2002 22 359-365
47. Pakkenberg B. pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990 47 1023-1028
48. Pellegrino LJ, Pellegrino AS, Cushman AJ. A Stereotaxic Atlas of the Rat Brain. New York Plenum 1979
49. Powell KJ, Binder T L, Hori S, etal. Neonatal ventral hippocampal lesions produce an elevation of DeltaFosB-like protein(s) in the rodent neocortex. Neuropsychopharmacology 2006 31 700-711
50. Rueter LE, Ballard ME, Gallagher KB, etal. Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology (Berl) 2004 176 312-319
51. Sams-Dodd F, Lipska BK, Weinberger DR. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) 1997 132 303-310
52. Schwabe K, Brosda J, Wegener N, etal. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in wistar rats. Pharmacol Biochem Behav 2005 80 213-219
53. Schwabe K, Koch M. Role of the medial prefrontal cortex in n-methyl-d-aspartate receptor antagonist induced sensorimotor gating deficit in rats. Neurosci Lett 2004 355 5-8
54. Shenton ME, Dickey CC, Frumin M, etal. A review of MRI findings in schizophrenia. Schizophr Res 2001 49 1-52
55. Simon H, Le Moal M, Galey D, etal. Silver impregnation of dopaminergic systems after radiofrequency and 6-OHDA lesions of the rat ventral. Brain Res 1976 115 215-231
56. Swerdlow NR, Braff DL, Geyer MA. Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci 1999 877 202-216
57. Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000 11 185-204
58. Swerdlow NR, Pitcher L, Noh HR, etal. Startle gating in rats is disrupted by chemical inactivation but not d2 stimulation of the dorsomedial thalamus. Brain Res 2002 953 246-254
59. Tregellas JR, Davalos DB, Rojas DC, etal. Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res 2007 92 262-272
60. Tregellas JR, Ellis J, Shatti S. Increased hippocampal, thalamic, and prefrontal hemodynamic response to an urban noise stimulus in schizophrenia. Am J Psychiatry 2009 166 354-360
61. van Eden CG. Development of connections between the mediodorsal nucleus of the thalamus and the prefrontal cortex in the rat. J Comp Neurol 1986 244 349-359
62. van Eden CG, van Hest A, van Haaren F, etal. Effects of neonatal mediodorsal thalamic lesions on structure and function of the rat prefrontal cortex. Brain Res Dev Brain Res 1994 80 26-34
63. Wan RQ, Corbett R. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology 1997 16 259-268
64. Weinberger DR. On localizing schizophrenic neuropathology. Schizophr Bull 1997 23 537-540
65. Wiley JL, Kennedy KL. Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats. J Neural Transm 2002 109 523-535
66. Wolf R, Dobrowolny H, Matzke K, etal. Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/CJ) with different hippocampal nmda receptor densities. Behav Brain Res 2006 166 78-84
67. Wolf R, Paelchen K, Matzke K, etal. Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density. Psychopharmacology (Berl) 2007 194 93-102
68. Young KA, Randall PK, Wilcox RE. Startle and sensorimotor correlates of ventral thalamic dopamine and gaba in rodents. Neuroreport 1995 6 2495-2499